Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib in Acquired Pure Red Cell Aplasia
NCT07031115Phase 2Withdrawn
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in acquired pure red cell aplasia (PRCA), sponsored by Peking Union Medical College Hospital. Planned start Oct 2026; status: withdrawn.
02
Drugs
linperlisib
03
Conditions
acquired pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT07031115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07031115.